Search Results

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/prevention & control ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/etiology

Academic Journal

Effect of Conventional Lifestyle Interventions on Type 2 Diabetes Incidence by Glucose-Defined Prediabetes Phenotype: An Individual Participant Data Meta-analysis of Randomized Controlled Trials.

Authors : Sathish T; Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, GA.; Emory Global Diabetes Research Center, Woodruff Health Sciences Center, Emory University, Atlanta, GA.

Source: Diabetes care [Diabetes Care] 2023 Nov 01; Vol. 46 (11), pp. 1903-1907.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Academic Journal

Differences between HbA 1c and glucose-related variables in predicting weight loss and glycaemic changes in individuals with overweight and hyperglycaemia - The PREVIEW trial.

Authors : P Silvestre M; Human Nutrition Unit, School of Biological Sciences, Department of Medicine, University of Auckland, Auckland, New Zealand; CINTESIS, NOVA Medical School, NMS, Universidade Nova de Lisboa, 1169-056, Lisboa, Portugal. Electronic address: .

Subjects: Hyperglycemia* ; Prediabetic State* ; Glucose Intolerance*

Source: Clinical nutrition (Edinburgh, Scotland) [Clin Nutr] 2023 May; Vol. 42 (5), pp. 636-643. Date of Electronic Publication: 2023 Mar 07.Publisher: Elsevier Country of Publication: England NLM ID: 8309603 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1983

Academic Journal

Circulating microRNAs from early childhood and adolescence are associated with pre-diabetes at 18 years of age in women from the PMNS cohort.

Authors : Joglekar MV; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.; Kunte PS

Subjects: Prediabetic State*/Prediabetic State*/Prediabetic State*/diagnosis ; Prediabetic State*/Prediabetic State*/Prediabetic State*/epidemiology ; Prediabetic State*/Prediabetic State*/Prediabetic State*/genetics

Source: Journal of developmental origins of health and disease [J Dev Orig Health Dis] 2022 Dec; Vol. 13 (6), pp. 806-811. Date of Electronic Publication: 2022 Apr 22.Publisher: Cambridge University Press Country of Publication: England NLM ID: 101517692 Publication Model: Print-Electronic Cited Medium: Internet

Academic Journal

Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.

Authors : Zhu R; Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.; Jalo E

Subjects: Prediabetic State*/Prediabetic State*/Prediabetic State*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Glucose Intolerance*

Source: Diabetes care [Diabetes Care] 2022 Nov 01; Vol. 45 (11), pp. 2698-2708.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Editorial & Opinion

We Need Lifestyle Modification Trials for the Reversal of Impaired Fasting Glucose.

Authors : Sathish T; Department of Global Health, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.; Shaw JE

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/prevention & control ; Glucose Intolerance*/Glucose Intolerance*/Glucose Intolerance*/therapy ; Prediabetic State*

Source: American journal of preventive medicine [Am J Prev Med] 2022 Oct; Vol. 63 (4), pp. 664-665.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8704773 Publication Model: Print Cited Medium: Internet ISSN: 1873-2607

Academic Journal

Pre-Diabetes Increases Tuberculosis Disease Severity, While High Body Fat Without Impaired Glucose Tolerance Is Protective.

Authors : Sinha R; Translational Research Institute, Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.; Ngo MD

Subjects: Diabetes Mellitus, Experimental* ; Diabetes Mellitus, Type 2* ; Glucose Intolerance*

Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Jul 06; Vol. 11, pp. 691823. Date of Electronic Publication: 2021 Jul 06 (Print Publication: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN:

Academic Journal

Dietary Pattern Trajectories from Youth to Adulthood and Adult Risk of Impaired Fasting Glucose: A 31-year Cohort Study.

Authors : Wu F; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.; Pahkala K

Subjects: Diet* ; Fasting* ; Feeding Behavior*

Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2021 Apr 23; Vol. 106 (5), pp. e2078-e2086.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Academic Journal

Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis.

Authors : Koopman ADM; Amsterdam UMC, location VUmc, Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, HV Amsterdam, the Netherlands.; Beulens JW

Subjects: Insulin Resistance*; Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*physiopathology

Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Mar 01; Vol. 105 (3).Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Academic Journal

Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.

Authors : de Ritter R; Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.; CARIM Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.

Subjects: Body Mass Index* ; Life Style*; Biomarkers/Biomarkers/Biomarkers/*blood

Source: BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2019 Nov 15; Vol. 7 (1), pp. e000787. Date of Electronic Publication: 2019 Nov 15 (Print Publication: 2019).Publisher: Published by BMJ in partnership with the American Diabetes Association Country of Publication: England NLM ID: 101641391 Publication Model:

Academic Journal

Real-world experience of metformin use in pregnancy: Observational data from the Northern Territory Diabetes in Pregnancy Clinical Register.

Authors : Maple-Brown LJ; Northern Territory Diabetes in Pregnancy Partnership

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetes, Gestational/Diabetes, Gestational/Diabetes, Gestational/*drug therapy

Source: Journal of diabetes [J Diabetes] 2019 Sep; Vol. 11 (9), pp. 761-770. Date of Electronic Publication: 2019 Feb 19.Publisher: Blackwell Publishing Asia Country of Publication: Australia NLM ID: 101504326 Publication Model: Print-Electronic

Academic Journal

Bone Turnover Markers in Men and Women with Impaired Fasting Glucose and Diabetes.

Authors : Holloway-Kew KL; Deakin University, Geelong, Australia. .; De Abreu LLF

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Bone Remodeling/Bone Remodeling/Bone Remodeling/*physiology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood

Source: Calcified tissue international [Calcif Tissue Int] 2019 Jun; Vol. 104 (6), pp. 599-604. Date of Electronic Publication: 2019 Jan 24.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Academic Journal

Glucose effectiveness is a critical pathogenic factor leading to glucose intolerance and type 2 diabetes: An ignored hypothesis.

Authors : Alford FP; Departments of Endocrinology and Diabetes and Medicine, St Vincent's Hospital, Fitzroy, Victoria, Australia.; University of Melbourne, Parkville, Victoria, Australia.

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*epidemiology ; Glucose Intolerance/Glucose Intolerance/Glucose Intolerance/*epidemiology

Source: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2018 May; Vol. 34 (4), pp. e2989. Date of Electronic Publication: 2018 Mar 24.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883450 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Academic Journal

Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin.

Authors : Cherney DZI; Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: .; Cooper ME

Subjects: Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use ; Blood Pressure/Blood Pressure/Blood Pressure/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

Source: Kidney international [Kidney Int] 2018 Jan; Vol. 93 (1), pp. 231-244. Date of Electronic Publication: 2017 Aug 30.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Academic Journal

Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.

Authors : Peters KE; Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Fremantle, Western Australia, Australia.; Proteomics International, Perth, Western Australia, Australia.

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood ; Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/*blood

Source: Diabetes care [Diabetes Care] 2017 Nov; Vol. 40 (11), pp. 1548-1555. Date of Electronic Publication: 2017 Aug 29.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium:

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*etiology ; Diabetes, Gestational/Diabetes, Gestational/Diabetes, Gestational/*physiopathology ; Glucose Intolerance/Glucose Intolerance/Glucose Intolerance/*etiology

Academic Journal

Conversion of gestational diabetes mellitus to future Type 2 diabetes mellitus and the predictive value of HbA 1c in an Indian cohort.

Authors : Gupta Y; Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India.; Kapoor D

Source: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2017 Jan; Vol. 34 (1), pp. 37-43. Date of Electronic Publication: 2016 Mar 17.Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Academic Journal

Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study.

Authors : Wang Z; Department of Cardiology, Anzhen Hospital.; Li W

Subjects: Hypertension*/Hypertension*/Hypertension*/physiopathology ; Hypertension*/Hypertension*/Hypertension*/complications ; Hypertension*/Hypertension*/Hypertension*/drug therapy

Source: Journal of hypertension [J Hypertens] 2024 Jul 01; Vol. 42 (7), pp. 1203-1211. Date of Electronic Publication: 2024 Mar 08.Publisher: Wolters Kluwer Health, Inc Country of Publication: Netherlands NLM ID: 8306882 Publication Model: Print-Electronic Cited Medium: Internet

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

Academic Journal

Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.

Authors : Natale P; Sydney School of Public Health, The University of Sydney, Sydney, Australia.; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 May 21; Vol. 5. Cochrane AN: CD015588. Date of Electronic Publication: 2024 May 21.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Academic Journal

Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex.

Authors : Yu MK; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Vart P

Subjects: Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Glucosides*/Glucosides*/Glucosides*/adverse effects ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use

Source: Journal of general internal medicine [J Gen Intern Med] 2024 May; Vol. 39 (6), pp. 921-930. Date of Electronic Publication: 2023 Dec 14.Publisher: Springer Country of Publication: United States NLM ID: 8605834 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Academic Journal

Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial.

Authors : Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Heart Failure and Biomarker Trials, Baim Institute for Clinical Research, Boston, MA. Electronic address: .

Subjects: Biomarkers*/Biomarkers*/Biomarkers*/blood ; Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/blood

Source: American heart journal [Am Heart J] 2024 May; Vol. 271, pp. 38-47. Date of Electronic Publication: 2024 Feb 22.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Academic Journal

Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.

Authors : Jin Q; Lau ESH ...

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetes Mellitus, Type 2* ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications

Source: Diabetologia [Diabetologia] 2024 May; Vol. 67 (5), pp. 837-849. Date of Electronic Publication: 2024 Feb 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

Academic Journal

Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease.

Authors : Neuen BL; The George Institute for Global Health, University of New South Wales, Sydney, Australia (B.L.N.).; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia (B.L.N.).

Source: Circulation [Circulation] 2024 Apr 16; Vol. 149 (16), pp. 1238-1240. Date of Electronic Publication: 2024 Apr 15.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Academic Journal

Rural and urban differences in the prevalence and determinants of Type-2 diabetes in Bangladesh.

Authors : Talukder A; Statistics Discipline, Science Engineering and Technology School, Khulna University, Khulna, Bangladesh.; National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Hypertension*/Hypertension*/Hypertension*/epidemiology ; Prediabetic State*/Prediabetic State*/Prediabetic State*/epidemiology

Source: PloS one [PLoS One] 2024 Apr 11; Vol. 19 (4), pp. e0298071. Date of Electronic Publication: 2024 Apr 11 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Subjects: Diabetes Mellitus, Type 2* ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy

Academic Journal

Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial.

Authors : Zhang Z; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.; Heerspink HJL

Source: The Lancet. Planetary health [Lancet Planet Health] 2024 Apr; Vol. 8 (4), pp. e225-e233.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101704339 Publication Model: Print Cited Medium: Internet ISSN: 2542-5196

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use

Academic Journal

The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study.

Authors : Ziser KED; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.; Wood S

Source: Journal of diabetes [J Diabetes] 2024 Apr; Vol. 16 (4), pp. e13507.Publisher: Blackwell Publishing Asia Country of Publication: Australia NLM ID: 101504326 Publication Model: Print Cited

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

Academic Journal

Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria.

Authors : Heerspink HJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands; The George Institute for Global Health, Sydney, New South Wales, Australia.

Source: American heart journal [Am Heart J] 2024 Apr; Vol. 270, pp. 125-135. Date of Electronic Publication: 2024 Feb 15.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Academic Journal

'We are somehow fixated on this being a diabetes drug': a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiation.

Authors : Milder TY; Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, New South Wales, Australia.

Subjects: Cardiologists* ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

Source: Internal medicine journal [Intern Med J] 2024 Apr; Vol. 54 (4), pp. 559-567. Date of Electronic Publication: 2023 Aug 07.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication Model: Print-Electronic

Editorial & Opinion

CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.

Authors : Schnell O; Forschergruppe Diabetes e. V, Helmholtz Center Munich, Ingolstaedter Landstraße 1, 85764, Neuherberg (Munich), Germany. .; Barnard-Kelly K

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/complications ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/diagnosis ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology

Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Mar 19; Vol. 23 (1), pp. 104. Date of Electronic Publication: 2024 Mar 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Academic Journal

Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications.

Authors : Arici M; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Hacettepe Universitesi, Ankara, Türkiye .; Assaad-Khalil SH

Source: BMJ open [BMJ Open] 2024 Mar 07; Vol. 14 (3), pp. e080891. Date of Electronic Publication: 2024 Mar 07.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Subjects: Glucose Intolerance*/Glucose Intolerance*/Glucose Intolerance*/drug therapy ; Glucose Intolerance*/Glucose Intolerance*/Glucose Intolerance*/metabolism ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism

Academic Journal

Liver-Selective Imidazolopyrazine Mitochondrial Uncoupler SHD865 Reverses Adiposity and Glucose Intolerance in Mice.

Authors : Beretta M; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia.; Dai Y

Source: Diabetes [Diabetes] 2024 Mar 01; Vol. 73 (3), pp. 374-384.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print Cited Medium: Internet ISSN:

Academic Journal

Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.

Authors : Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; The George Institute for Global Health, Sydney, New South Wales, Australia.

Subjects: Benzhydryl Compounds* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucosides*

Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2024 Feb 28; Vol. Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium: Internet ISSN:

Academic Journal

Muscle Quality in Relation to Prediabetes Phenotypes: A Population-Based Study With Mediation Analysis.

Authors : Qiu S; Department of General Practice, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing 210009, China.; Research and Education Centre of General Practice, Zhongda Hospital, Southeast University, Nanjing 210009, China.

Subjects: Prediabetic State* ; Glucose Intolerance*; Humans

Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Feb 20; Vol. 109 (3), pp. e1151-e1158.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Academic Journal

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.

Authors : Neuen BL; The George Institute for Global Health, University of New South Wales, Sydney, Australia (B.L.N., H.J.L.H., R.A.F., C.A., B.N., V.P.).; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia (B.L.N.).

Source: Circulation [Circulation] 2024 Feb 06; Vol. 149 (6), pp. 450-462. Date of Electronic Publication: 2023 Nov 12.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

Academic Journal

Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial.

Authors : Sharma A; Centre for Outcomes Research and Evaluation Research Institute of the McGill University Health Centre Montreal QC Canada.; Division of Cardiology McGill University Health Centre, McGill University Montreal QC Canada.

Source: Journal of the American Heart Association [J Am Heart Assoc] 2024 Feb 06; Vol. 13 (3), pp. e031586. Date of Electronic Publication: 2024 Jan 19.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Academic Journal

Carnosine supplementation improves glucose control in adults with pre-diabetes and type 2 diabetes: A randomised controlled trial.

Authors : Hariharan R; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton VIC, Australia.; Cameron J

Subjects: Carnosine*/Carnosine*/Carnosine*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

Source: Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2024 Feb; Vol. 34 (2), pp. 485-496. Date of Electronic Publication: 2023 Oct 14.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111474 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Academic Journal

Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.

Authors : Vart P; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Source: The journals of gerontology. Series A, Biological sciences and medical sciences [J Gerontol A Biol Sci Med Sci] 2024 Feb 01; Vol. 79 (2).Publisher: published on behalf of the Gerontological Society of America by Oxford University Press Country of Publication: United States NLM ID: 9502837

Academic Journal

Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification.

Authors : Pollock C; Royal North Shore Hospital, Kolling Institute, University of Sydney, St Leonards, New South Wales, Australia.; Sanchez JJG

Source: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2024 Feb; Vol. 41 (2), pp. e15200. Date of Electronic Publication: 2023 Aug 26.Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Glucose Intolerance*/Glucose Intolerance*/Glucose Intolerance*/complications ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/complications

Academic Journal

Effects of photoperiod and food on glucose intolerance and subsequent ocular pathology in the fat sand rat.

Authors : Bilu C; School of Zoology, Tel-Aviv University, 69978, Ramat Aviv, Tel Aviv, Israel. .; Butensky N

Source: Scientific reports [Sci Rep] 2024 Jan 03; Vol. 14 (1), pp. 403. Date of Electronic Publication: 2024 Jan 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Academic Journal

Hybrid Evaluation of a Lifestyle Change Program to Prevent the Development of Type 2 Diabetes Among Individuals With Prediabetes: Intended and Observed Changes in Intervening Mechanisms.

Authors : Huttunen-Lenz M; University of Education Schwäbisch Gmünd, Schwäbisch Gmünd, Germany.; Hansen S

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/prevention & control ; Prediabetic State*/Prediabetic State*/Prediabetic State*/therapy ; Self Efficacy*

Source: Journal of primary care & community health [J Prim Care Community Health] 2024 Jan-Dec; Vol. 15, pp. 21501319241248223.Publisher: Sage Publications Country of Publication: United States NLM ID: 101518419 Publication Model: Print Cited Medium: Internet ISSN:

Subjects: Diabetes Mellitus, Type 2* ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology

Academic Journal

Combination therapy with kidney protective therapies: optimizing the benefits?

Authors : Kotwal S; The George Institute for Global Health, UNSW, Sydney, NSW 2052, Australia.; Prince of Wales Hospital, UNSW, Sydney, New South Wales.

Source: Current opinion in nephrology and hypertension [Curr Opin Nephrol Hypertens] 2024 Jan 01; Vol. 33 (1), pp. 136-143. Date of Electronic Publication: 2023 Sep 28.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9303753 Publication Model: Print-Electronic Cited Medium: Internet

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*

Academic Journal

Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.

Authors : Sridhar VS; Division of Nephrology, University Health Network, University of Toronto, Toronto, ON, Canada. .; Limonte CP

Source: Diabetologia [Diabetologia] 2024 Jan; Vol. 67 (1), pp. 3-18. Date of Electronic Publication: 2023 Oct 06.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Academic Journal

Cognitive deficits among people with schizophrenia and prediabetes or diabetes.

Authors : John AP; University of Western Australia, Perth, Australia.; Bentley Health Service, Bentley, Australia.

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/complications ; Schizophrenia*/Schizophrenia*/Schizophrenia*/epidemiology ; Prediabetic State*/Prediabetic State*/Prediabetic State*/epidemiology

Source: Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2024 Jan; Vol. 149 (1), pp. 65-76. Date of Electronic Publication: 2023 Nov 10.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370364 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Academic Journal

Making prediabetes visible in primary health care: a qualitative study of health care professionals' perspectives.

Authors : Harcke K; Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institutet, Huddinge, Region Stockholm, Sweden. .; Academic Primary Health Care Centre, Solnavägen 1E Torsplan, plan 7, Stockholm, 11365, Region Stockholm, Sweden. .

Source: BMC primary care [BMC Prim Care] 2023 Dec 13; Vol. 24 (1), pp. 266. Date of Electronic Publication: 2023 Dec 13.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9918300889006676 Publication Model: Electronic Cited Medium: Internet ISSN:

Academic Journal

Higher Short-Chain Fermentable Carbohydrates Are Associated with Lower Body Fat and Higher Insulin Sensitivity in People with Prediabetes.

Authors : Chu NHS; Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; He J

Subjects: Insulin Resistance* ; Prediabetic State* ; Glucose Intolerance*

Source: Nutrients [Nutrients] 2023 Dec 11; Vol. 15 (24). Date of Electronic Publication: 2023 Dec 11.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

Academic Journal

Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials.

Authors : Fletcher RA; The George Institute for Global Health, UNSW, Sydney, New South Wales, Australia.; Jongs N

Source: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2023 Dec 01; Vol. 34 (12), pp. 1965-1975. Date of Electronic Publication: 2023 Oct 25.Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model:

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

Academic Journal

Blood Pressure Effects of SGLT2 Inhibitors: Mechanisms and Clinical Evidence in Different Populations.

Authors : Beal B; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia.; Schutte AE

Source: Current hypertension reports [Curr Hypertens Rep] 2023 Dec; Vol. 25 (12), pp. 429-435. Date of Electronic Publication: 2023 Nov 10.Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100888982 Publication Model: Print-Electronic Cited Medium: Internet

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

Academic Journal

Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease.

Authors : Chan KW; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Division of Nephrology, Department of Medicine, The University of Hong Kong, Hong Kong SAR

Source: Kidney international [Kidney Int] 2023 Dec; Vol. 104 (6), pp. 1219-1226. Date of Electronic Publication: 2023 Aug 31.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/diagnosis

Academic Journal

Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.

Authors : Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.

Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Nov 28; Vol. 22 (1), pp. 330. Date of Electronic Publication: 2023 Nov 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

Academic Journal

Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial.

Authors : Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; The George Institute for Global Health, Sydney, NSW, Australia. Electronic address: .

Source: Lancet (London, England) [Lancet] 2023 Nov 25; Vol. 402 (10416), pp. 2004-2017. Date of Electronic Publication: 2023 Nov 03.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X

Academic Journal

Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial.

Authors : Saadati S; Department of Medicine, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3168, Australia.; Cameron J

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Prediabetic State*/Prediabetic State*/Prediabetic State*/drug therapy ; Carnosine*

Source: Nutrients [Nutrients] 2023 Nov 19; Vol. 15 (22). Date of Electronic Publication: 2023 Nov 19.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: